|Articles|March 30, 2020

Contagion Live News Network: Coronavirus Updates for March 30, 2020

Stay up to date with our daily COVID-19 update.

Welcome to the Contagion Live News Network. I’m Grant Gallagher and this is the COVID-19 update for Monday, March 30th, 2020.

The United States has extended social distancing measures through the end of April, after reassessment of an earlier timeline floated which would begin to reopen the country by Easter.

Over the weekend, Contagion covered the need to prepare for patients to recover from COVID-19.

Harvard Medical School’s Daniel Grabowski, PhD noted that “Many patients with COVID-19 will need post-acute care to recuperate from their infection, however, post-acute care facilities currently lack the capacity and capability to safely treat patients with COVID-19 as they transition from the hospital to other care settings or to their homes."

The US Food and Drug Administration began working with diagnostic developers in January and to date has engaged with 230 test developers who have or are expected to submit requests for emergency use authorization. As of March 30th, 20 authorizations have been granted. Among these was a 5-minute diagnostic from Abbott. Additionally, more than 110 laboratories have notified the FDA that they have begun using their own tests.

The total number of cases in the US has now passed 153,000 with over 2800 deaths.

Around the world, there are over 760,000 cases. There have been over 36,000 reported deaths, but also at least 158,000 recoveries.

For other stories relevant to COVID-19 and the latest infectious disease news, visit ContagionLive.com. To track the spread of infectious diseases in the United States and abroad, be sure to use the Contagion Outbreak Monitor.

For the Contagion Live News Network, I’m Grant Gallagher. Thanks for listening.


Related to this article

Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Measles Update: October 9, 2026
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
FAQ: What You Need to Know About Measles in 2026
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.